Tumor vascularity: Evaluation in a murine model with contrast-enhanced color Doppler US - Effect of angiogenesis inhibitors

Radiology

Volumn 222, Issue 2, 2002, Pages 460-467

  Iordanescu, Irina ^a   Becker, Christian ^a   Zetter, Bruce ^a   Dunning, Patricia ^a   Taylor, George A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Agiogenesis; Prostate neoplasms; Prostate neoplasms, US; Ultrasound (US), Doppler studies

Indexed keywords

ANGIOGENESIS INHIBITOR; CONTRAST MEDIUM; PERFLEXANE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; VIRUS VECTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EVALUATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; TRANSDUCER; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM;

EID: 0036153993     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2222010660     Document Type: Article

References (22)

1. Tumor angiogenesis: Therapeutic implications
2. Angiogenesis and tumor metastasis
3. Angiogenesis in cancer and other disease
4. Orthotopic models are necessary to predict therapy of transplantable tumors in mice
5. Sonographic evaluation of orthotopic bladder tumors in mice treated with TNP 470, an angiogenic inhibitor
6. Ultrasound backscatter microscope analysis of mouse melanoma progression
7. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice
8. Mouse models of prostate cancer
9. Prostate cancer in a transgenic mouse
10. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation
11. Pathologic progression of autochthonous prostate cancer in the TRAMP model
12. Ultrasound contrast agents: A review
13. Some statistical methods useful in circulation research
14. Intratumor microvessel density as a prognostic factor in cancer
15. What is the evidence that tumors are angiogenesis dependent?
16. New perspectives in clinical oncology from angiogenesis research
17. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
18. Antiangiogenic agents can increase tumor oxygenation and response to radiation therapy
19. New hemodynamic approach to angiogenesis: Color and pulsed Doppler ultrasonography
20. Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor vessel formation monitored by Doppler ultrasonography
21. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model
22. Barriers to drug delivery in solid tumors